Spark Therapeutics ID YOUR IRD® gene testing initiative

Philadelphia,  PA 
United States
  • Booth: 81

Thank you for visiting Spark Therapeutics

Spark Therapeutics is committed to increasing information and knowledge about the diagnosis of a broad range of inherited retinal diseases.  The only way to confirm that your patient has an inherited retinal disease (IRD) is with a genetic test. Through the ID YOUR IRD gene testing initiative, Spark Therapeutics supports people living with certain IRDs by providing genetic information that can empower their decisions. The ID YOUR IRD panel tests for mutations in approximately [250] genes that are associated with IRDs.

For US Healthcare Professionals Only.

For technical assistance with this webpage please click here.